Skip to content

Taysha Gene Therapies, Inc. TSHA Gain (loss) on extinguishment of debt

Gain (loss) on extinguishment of debt at other companies

Axos Financial logo
Axos FinancialAX
$0
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-$1.8M
ServiceTitan, Inc. logo
ServiceTitan, Inc.TTAN
-$372K
Scholar Rock logo
Scholar RockSRRK
-$3.34M
Sphere Entertainment logo
Sphere EntertainmentSPHR
-$2.07M
Silgan Holdings logo
Silgan HoldingsSLGN
-$1.02M

Other financials

Income statement

See full
Revenue--100%
Operating income-$43.5M-103%
Net income-$42.4M-97.0%
EPS (diluted)-$0.12-50.0%

Balance sheet

See full
Cash & equivalents$276.6M+137%
Total debt$68.6M+11.2%
Total equity$211.9M+285%
Total assets$300.4M+117%

Cash flow

See full
Operating cash flow-$40.9M-85.6%
CapEx$24.0K-93.7%
Free cash flow-$40.9M-82.6%

Valuation

See full
Market cap$1.99B+351%

Profitability

See full
Operating margin-1,774.4%+1,437pp
Net margin-1,738.4%+1,407pp
FCF margin-1,503.6%+621pp

Returns & leverage

See full
Return on equity-97.3%-27.3pp
Debt / equity0.3×-0.8×
Current ratio14×+8.7×

Where this comes from

Reported directly by Taysha Gene Therapies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainsLossesOnExtinguishmentOfDebt.

The official record: Taysha Gene Therapies, Inc.’s 10-K, filed February 26, 2025, on SEC EDGAR. View the filing →

Ask your AI about Taysha Gene Therapies, Inc.'s gain (loss) on extinguishment of debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Taysha Gene Therapies, Inc.'s gain (loss) on extinguishment of debt?
Taysha Gene Therapies, Inc. (TSHA) reported gain (loss) on extinguishment of debt of -$349.5K in Q4 2023.
What does gain (loss) on extinguishment of debt mean?
Gains or losses from retiring debt before maturity — gains when debt is repurchased below par, losses when premiums are paid for early redemption.